Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02993185 · ClinicalTrials.gov registry record · NA
Making Healthy Decisions: A Trial Evaluating the "Your Move" Teen Pregnancy-prevention Intervention
A NA study, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 808
- Enrollment target
NCT02993185: Completed NA study, sponsored by Carnegie Mellon University.
NCT02993185 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 808 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02993185, a NA study, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 808 participants
- Enrollment target
Study Summary
The purpose of Making Healthy Decisions is to design and rigorously evaluate a new sexual health education program, "Your Move" (YM) against a nutrition control program, "Eat Smart" (ES). YM is intended to improve teen females' (ages 14-19) ability to make healthy sexual decisions with the ultimate goal of reducing unplanned pregnancies and STIs.
Primary Outcome
Number of partners with whom had vaginal sex
Interventions
- BEHAVIORAL Your Move
- BEHAVIORAL Eat Smart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 808 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT02993185 record still lists
NCT02993185 is an interventional study that assigns participants to a tested intervention. The registered 808 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Your Move is the first listed.
NCT02993185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02993185 about?
NCT02993185 is a clinical study titled "Making Healthy Decisions: A Trial Evaluating the "Your Move" Teen Pregnancy-prevention Intervention". The purpose of Making Healthy Decisions is to design and rigorously evaluate a new sexual health education program, "Your Move" (YM) against a nutrition control program, "Eat Smart" (ES). YM is intended to improve teen females' (ages 14-19) ability to make healthy sexual decisions with the ultimate ...
What is the current status of trial NCT02993185?
This trial is currently completed. It is a NA study. The enrollment target is 808 participants. The study started on 2016-10-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02993185?
The interventions under investigation include: Your Move (BEHAVIORAL), Eat Smart (BEHAVIORAL).
Who is sponsoring clinical trial NCT02993185?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02993185's enrollment target sits among peer trials
808 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI